about
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).Hyponatremia: an update on current pharmacotherapy.Plasma copeptin, a possible prognostic marker in cirrhosis.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Conivaptan: promise of treatment in heart failure.
@en
Conivaptan: promise of treatment in heart failure.
@nl
type
label
Conivaptan: promise of treatment in heart failure.
@en
Conivaptan: promise of treatment in heart failure.
@nl
prefLabel
Conivaptan: promise of treatment in heart failure.
@en
Conivaptan: promise of treatment in heart failure.
@nl
P2093
P2860
P1476
Conivaptan: promise of treatment in heart failure.
@en
P2093
Darshak H Karia
Mitul Afiniwala
Mohammad Z Hoque
Nazmul Huda
Nitin Verma
Pradeep Arumugham
P2860
P304
P356
10.1517/14656560903173237
P407
P577
2009-09-01T00:00:00Z